Results 201 to 210 of about 548,791 (262)

Liver Organoids: From Disease Modelling to Regenerative Medicine

open access: yesCell Proliferation, EarlyView.
Liver organoids provide a versatile platform for disease modelling and drug discovery, leveraging stem cells and engineering techniques. They bridge research and clinical applications, offering significant potential for advancing precision medicine and regenerative therapies for liver diseases.
Tiepeng Wang   +5 more
wiley   +1 more source

The different face of skin‐rash induced by brentuximab vedotin

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri   +11 more
wiley   +1 more source

A prospective, phase IV study of ixazomib, pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

open access: yes
British Journal of Haematology, EarlyView.
Runfeng Zhang   +15 more
wiley   +1 more source

In Vitro Evaluation of the Efficacy of Liquid Platelet‐Rich Fibrin (PRF) for Maintaining and Restoring Periodontal Ligament Cell Viability in Avulsed Teeth After 3 and 4 h of Extra‐Alveolar Dry Time

open access: yesDental Traumatology, EarlyView.
ABSTRACT Background/Aim This in vitro study evaluated whether liquid platelet‐rich fibrin could maintain or recover periodontal ligament cell viability in extracted human teeth after three and four hours of dry extra‐alveolar time. Material and Methods Sixty‐six erupted third molars with complete root formation were allocated to four groups: three‐hour
Tatiana Carvalho Kowaltschuk   +6 more
wiley   +1 more source

Upfront Autologous Stem Cell Transplantation in First Complete Remission for Advanced-Stage Extra-Nodal NK/T-Cell Lymphoma: A Multicenter Retrospective Study. [PDF]

open access: yesAm J Hematol
Hu S   +18 more
europepmc   +1 more source

Bridging Randomized Trial Efficacy and Real‐World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real‐World Evidence for Individualized Care

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Multiple myeloma (MM) is predominantly a disease of older adults, yet the randomized clinical trials (RCTs) that define standards of care are conducted largely in younger, fitter, and less comorbid populations. This creates a systematic mismatch between the populations generating evidence and those receiving treatment in routine practice ...
Enrica Antonia Martino   +13 more
wiley   +1 more source

Outcomes of refractory and early‐relapsed large B‐cell lymphoma patients after first‐line treatment in the prospective Real‐world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre‐CAR T era

open access: yes
British Journal of Haematology, EarlyView.
Stéphanie Guidez   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy